An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Why we must screen early in life for hypertrophic cardiomyopathy
New study aims to change screening guidelines
Assessing the value of genetic testing
Answers needed as policy tries to keep up with innovation